Echocardiography Service Automatically Identifies Coronary Artery Disease
By MedImaging International staff writers Posted on 21 Jan 2021 |
Image: The EchoGo Pro clinical workflows for CAD analysis (Photo courtesy of Ultromics)
An artificial intelligence (AI) powered, outcomes-driven, decision support tool improves the diagnostic accuracy of clinicians for coronary artery disease (CAD).
The Ultromics (Oxford, United Kingdom) EchoGo Pro is a fully automated solution for echocardiography and strain analysis. The cloud-based Software-as-a-Service (SaaS) platform uses AI to power the diagnostic pathway, providing near-instant reports without any need for physical software on site. EchoGo Pro complements EchoGo Core, a software application that measures standard cardiac parameters, including ejection fraction (EF), global longitudinal dtrain (GLS), and left ventricular (LV) volume, and also analyzes echocardiogram (ECG) cardiac parameters.
For Pro, the anonymized echocardiogram dataset is transferred and processed through the application’s workflow, and an auto-contouring algorithm places points around the LV that sufficiently capture the LV shape; these contours are then used for calculating geometric parameters. By automating ECG analysis as part of the cloud service, a complete accurate analysis can be delivered within minutes, and with zero variability, in a zero-click workflow, aiding identification of CAD. EchoGo Pro and EchoGo Core will be offered together in the EchoGo suite.
“Heart disease is the biggest killer globally, and this number is increasing daily. COVID-19 has placed an even greater pressure on cardiac care and looks likely to have lasting implications in terms of its impact on the heart,” said Ross Upton, MD, founder and CEO of Ultromics. “The healthcare industry needs to quickly pivot towards AI powered automation to reduce the time to diagnosis and improve patient care. We are making the EchoGo suite as complete and automated as possible to help clinicians rapidly assess disease and provide early, appropriate intervention.”
Cardiac ultrasound, or echocardiography, is a noninvasive diagnostic modality that can provide detailed hemodynamic information rapidly at the patient bedside. It was first adopted for diagnostic purposes in the 1960s as an inexpensive way to expedite diagnosis and management of imminently life-threatening cardiac disease, including pericardial tamponade, acute coronary syndrome (ACS), cardiomyopathy, pulmonary embolism (PE), and aortic dissection. Cardiac ultrasound can also differentiate shock states and guide resuscitative measures.
Related Links:
Ultromics
The Ultromics (Oxford, United Kingdom) EchoGo Pro is a fully automated solution for echocardiography and strain analysis. The cloud-based Software-as-a-Service (SaaS) platform uses AI to power the diagnostic pathway, providing near-instant reports without any need for physical software on site. EchoGo Pro complements EchoGo Core, a software application that measures standard cardiac parameters, including ejection fraction (EF), global longitudinal dtrain (GLS), and left ventricular (LV) volume, and also analyzes echocardiogram (ECG) cardiac parameters.
For Pro, the anonymized echocardiogram dataset is transferred and processed through the application’s workflow, and an auto-contouring algorithm places points around the LV that sufficiently capture the LV shape; these contours are then used for calculating geometric parameters. By automating ECG analysis as part of the cloud service, a complete accurate analysis can be delivered within minutes, and with zero variability, in a zero-click workflow, aiding identification of CAD. EchoGo Pro and EchoGo Core will be offered together in the EchoGo suite.
“Heart disease is the biggest killer globally, and this number is increasing daily. COVID-19 has placed an even greater pressure on cardiac care and looks likely to have lasting implications in terms of its impact on the heart,” said Ross Upton, MD, founder and CEO of Ultromics. “The healthcare industry needs to quickly pivot towards AI powered automation to reduce the time to diagnosis and improve patient care. We are making the EchoGo suite as complete and automated as possible to help clinicians rapidly assess disease and provide early, appropriate intervention.”
Cardiac ultrasound, or echocardiography, is a noninvasive diagnostic modality that can provide detailed hemodynamic information rapidly at the patient bedside. It was first adopted for diagnostic purposes in the 1960s as an inexpensive way to expedite diagnosis and management of imminently life-threatening cardiac disease, including pericardial tamponade, acute coronary syndrome (ACS), cardiomyopathy, pulmonary embolism (PE), and aortic dissection. Cardiac ultrasound can also differentiate shock states and guide resuscitative measures.
Related Links:
Ultromics
Latest Ultrasound News
- Largest Model Trained On Echocardiography Images Assesses Heart Structure and Function
- Groundbreaking Technology Enables Precise, Automatic Measurement of Peripheral Blood Vessels
- Deep Learning Advances Super-Resolution Ultrasound Imaging
- Novel Ultrasound-Launched Targeted Nanoparticle Eliminates Biofilm and Bacterial Infection
- AI-Guided Ultrasound System Enables Rapid Assessments of DVT
- Focused Ultrasound Technique Gets Quality Assurance Protocol
- AI-Guided Handheld Ultrasound System Helps Capture Diagnostic-Quality Cardiac Images
- Non-Invasive Ultrasound Imaging Device Diagnoses Risk of Chronic Kidney Disease
- Wearable Ultrasound Platform Paves Way for 24/7 Blood Pressure Monitoring On the Wrist
- Diagnostic Ultrasound Enhancing Agent to Improve Image Quality in Pediatric Heart Patients
- AI Detects COVID-19 in Lung Ultrasound Images
- New Ultrasound Technology to Revolutionize Respiratory Disease Diagnoses
- Dynamic Contrast-Enhanced Ultrasound Highly Useful For Interventions
- Ultrasensitive Broadband Transparent Ultrasound Transducer Enhances Medical Diagnosis
- Artificial Intelligence Detects Heart Defects in Newborns from Ultrasound Images
- Ultrasound Imaging Technology Allows Doctors to Watch Spinal Cord Activity during Surgery